Evidence map›Paper›PMID 31590184›Full record

ArticleAnnals of internal medicine2019

Ensuring Sustainability of Needed Antibiotics: Aiming for the DART Board.

Brad Spellberg, Travis B Nielsen, David N Gilbert, Andrew F Shorr, Eric P Brass

Open access · greenAbstract read
In one paragraph

Article in Annals of internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Brad SpellbergLos Angeles County and University of Southern California Medical Center, Los Angeles, California (B.S.).
Travis B NielsenStritch School of Medicine and Parkinson School of Health Sciences and Public Health, Loyola University Chicago, Maywood, Illinois (T.B.N.).
David N GilbertProvidence Portland Medical Center and University of Oregon Health Sciences School of Medicine, Portland, Oregon (D.N.G.).
Andrew F ShorrPulmonary and Critical Care Medicine Service, MedStar Washington Hospital Center, Washington, DC (A.F.S.).
Eric P BrassDavid Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California (E.P.B.).
Los Angeles Medical Center · USLoyola University Chicago · USMedStar Washington Hospital Center · USProvidence Portland Medical Center · USUniversity of California, Los Angeles · US

Funding

MAb Passive Vaccination against Acinetobacter baumanniiR01AI130060 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRAD J SPELLBERG · 2017 to 2026
$6.7M
Humanized Monoclonal Antibody to Treat Acinetobacter InfectionsR42AI106375 · NIAID · BIOLOGICAL ANTI-INFECTIVE MEDICINES, LLC · PI ISLAM, KHALID · 2016 to 2018
$3.1M
Transferrin Combination Therapy to Address Antimicrobial ResistanceR01AI117211 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SPELLBERG, BRAD J · 2016 to 2019
$2.7M
Humanized Monoclonal Antibodies to Treat Acinetobacter InfectionsR41AI106375 · NIAID · BIOLOGICAL ANTI-INFECTIVE MEDICINES, LLC · PI SPELLBERG, BRAD J · 2013 to 2014
$574k
AHRQ HHS R01 HS025690NIAID NIH HHS R01 AI117211NIAID NIH HHS R01 AI130060NIAID NIH HHS R41 AI106375NIAID NIH HHS R42 AI106375
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsDrug DevelopmentDrug DiscoveryDrug Resistance, BacterialHumansUnited StatesAnti-Bacterial Agents

Identifiers

PMID31590184
PMCPMC7296826
OpenAlexW2979630260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.